» Articles » PMID: 3358734

Quantification of Cellular Proliferation in Experimental Proliferative Vitreoretinopathy

Overview
Journal Arch Ophthalmol
Specialty Ophthalmology
Date 1988 May 1
PMID 3358734
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Proliferation of host cells from around the optic nerve head has recently been implicated in the development of experimental proliferative vitreoretinopathy in rabbit eyes injected with homologous fibroblasts. We used liquid scintillation spectrometry to quantitate the tritiated thymidine incorporation into cells in the vitreous, retina, and optic nerve head following intravitreal injection of 250,000 homologous dermal fibroblasts. Cellular proliferation peaked three days after injection of the fibroblasts. The amount of tritiated thymidine incorporation that occurred three days following injection of irradiated homologous fibroblasts (incapable of cellular division) was not significantly different than that following injection of normal homologous fibroblasts, indicating that host cells were responsible for most of the cellular proliferation. Treatment with fluorouracil or triamcinolone acetonide completely arrested cellular proliferation following injection of normal fibroblasts.

Citing Articles

Cytotoxic effects of antiproliferative agents on human retinal glial cells in vitro.

Cai J, Wei R, Ma X, Zhu H, Li Y Int Ophthalmol. 2003; 24(4):225-31.

PMID: 12678400 DOI: 10.1023/a:1022509614815.


Hypoxia precedes the development of experimental preretinal neovascularization.

Handa J, Berkowitz B, Wilson C, Ando N, Sen H, Jaffe G Graefes Arch Clin Exp Ophthalmol. 1996; 234(1):43-6.

PMID: 8750849 DOI: 10.1007/BF00186517.


Corticosteroids and daunomycin in the prevention of experimental proliferative vitreoretinopathy induced by macrophages.

Hui Y, Liang H, Cai Y, Kirchhof B, Heimann K Graefes Arch Clin Exp Ophthalmol. 1993; 231(2):109-14.

PMID: 8444357 DOI: 10.1007/BF00920223.


Evaluation of a single intravitreal injection of 5-fluorouracil in vitrectomy cases.

Blankenship G Graefes Arch Clin Exp Ophthalmol. 1989; 227(6):565-8.

PMID: 2696670 DOI: 10.1007/BF02169453.


Daunorubicin treatment in a refined experimental model of proliferative vitreoretinopathy.

Khawly J, Saloupis P, Hatchell D, MACHEMER R Graefes Arch Clin Exp Ophthalmol. 1991; 229(5):464-7.

PMID: 1937080 DOI: 10.1007/BF00166311.